Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
Zhuokai Zhuang(Sun Yat-sen University), Yanxin Luo(Sun Yat-sen University), Meijin Huang(Sun Yat-sen University), Zongchao Liu(Columbia University), Peiyi Xie(Zhongshan Hospital), Huichuan Yu(Sun Yat-sen University), Xiaochun Meng(Sun Yat-sen University), Juan Li(Shandong First Medical University), Xiaolin Wang(Dalian Medical University), Fei Xiong(General Hospital of Central Theater Command), Yanhong Deng(Sun Yat-sen University), Ping Lan(Sun Yat-sen University), Jiancong Hu(Sun Yat-sen University)
Cited by 23
Related Papers
High-Throughput Synthesis of Single-Layer MoS<sub>2</sub> Nanosheets as a Near-Infrared Photothermal-Triggered Drug Delivery for Effective Cancer Therapy
|ACS Nano|2014|921
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410